Island Pharmaceuticals (ASX: ILA) Share Price

ILA

$0.38▲+7.04%

$95.0MRank #834 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$95.0M

Volume

403K

P/E Ratio

-5.66

EPS

-$0.019

Dividend Yield

0.00%

52-Week High

$0.63

52-Week Low

$0.13

Beta

0.163

Island Pharmaceuticals (ASX: ILA) is an Australian-listed company in the Healthcare sector with a market capitalisation of $95.0M and the 834th-largest security on the ASX by market capitalisation. The ILA share price is $0.38, up 7.04% today and up 89.19% over the past 12 months. Shares have traded between $0.13 and $0.63 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Island Pharmaceuticals reported revenue of $0 and a net loss of $4.8M.

Charts

$0.35

24H Range

$0.345

$0.39

52-Week Range

$0.13

$0.63

About Island Pharmaceuticals Limited

Island Pharmaceuticals Limited functions as a pharmaceutical enterprise dedicated to drug discovery and repurposing, with a specific focus on creating preventative or therapeutic solutions for viral infections. Its lead therapeutic agent, ISLA-101, is currently under development for both preventing and treating dengue fever and other illnesses transmitted by mosquitoes. The company participates in various strategic collaborations, including a research partnership with Monash University to evaluate known molecules against host targets, and a research and development alliance with Griffith University aimed at screening for active antiviral compounds through a systematic repurposing approach. Additionally, Island Pharmaceuticals has a research agreement with Compounds Australia, providing access to an extensive drug library containing roughly 4,500 molecules for potential drug repurposing and pipeline enhancement. In anticipation of its ISLA-101 Phase II clinical study, the company has also established a cooperative research and development pact with the U.S. Army. Other key agreements include a supply contract with Catalent for the production of Fenretinide softgels for individuals participating in dengue fever trials, and the entitlement to reference the National Cancer Institute's Investigational New Drug (IND) application for ISLA-101. The company, founded in 2017, is based in Camberwell, Australia.

IPO Date

13 Apr 2021

CEO

David Charles Foster

Website

islandpharmaceuticals.com

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-4.8M
Total Assets	$8.0M
Total Debt	$0
Free Cash Flow	$-2.0M
Return on Equity	-67.23%
Profit Margin	—
Operating Margin	—

ILA Frequently Asked Questions

What is the Island Pharmaceuticals (ASX: ILA) share price?

The ILA share price is $0.38, up 7.04% for the day, based on the latest available ASX market data.

What is Island Pharmaceuticals's market capitalisation?

Island Pharmaceuticals has a market capitalisation of $95.0M, making it the 834th-largest security listed on the ASX.

Does Island Pharmaceuticals pay a dividend?

ILA does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Island Pharmaceuticals profitable?

In its most recent reported period (ending 31 Dec 2025), ILA reported revenue of $0 and a net loss of $4.8M.

How many ILA shares are on issue?

Island Pharmaceuticals has approximately 250,066,137 shares on issue, based on its market capitalisation of $95.0M and current share price.

What sector is Island Pharmaceuticals in?

Island Pharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Island Pharmaceuticals list on the ASX?

Island Pharmaceuticals listed on the Australian Securities Exchange on 13 Apr 2021.

Latest News

When Can We Expect A Profit From Island Pharmaceuticals Limited (ASX:ILA)?

simplywall.st19 May 2026

When Can We Expect A Profit From Island Pharmaceuticals Limited (ASX:ILA)? simplywall.st

Island Pharmaceuticals expands US Army partnership for Marburg study

grafa.com10 June 2026

Island Pharmaceuticals expands US Army partnership for Marburg study grafa.com

Island Pharmaceuticals (ASX:ILA) Gains as Galidesivir Development Reaches New Stage

Kalkine4 June 2026

Island Pharmaceuticals (ASX:ILA) Gains as Galidesivir Development Reaches New Stage Kalkine

Insights: Island Pharmaceuticals Ltd (ASX:ILA)

smallcaps.com.au30 Oct 2025

Insights: Island Pharmaceuticals Ltd (ASX:ILA) smallcaps.com.au

Inside Biotech: Island Pharmaceuticals pushes deeper into US biodefence as Ebola fears spark interest

Proactive financial news19 May 2026

Inside Biotech: Island Pharmaceuticals pushes deeper into US biodefence as Ebola fears spark interest Proactive financial news

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
SPLStarpharma Holdings Limited	$286.2M	$0.68	27.58	0.00%	▲+1.49%
RCERecce Pharmaceuticals Ltd	$144.6M	$0.50	-2.84	0.00%	▲+2.04%
ACWActinogen Medical Limited	$122.0M	$0.034	-4.28	0.00%	–+0.00%
ATHAlterity Therapeutics Limited	$107.7M	$0.495	-2.12	0.00%	▲+11.24%
ALAArovella Therapeutics Limited	$81.0M	$0.067	-14.80	0.00%	▲+1.52%
BIOBiome Australia Limited	$62.7M	$0.275	19.71	0.00%	–+0.00%
ATXAmplia Therapeutics Limited	$56.5M	$0.11	-8.54	0.00%	–+0.00%
TRJTrajan Group Holdings Limited	$49.7M	$0.325	-59.43	0.00%	▲+10.17%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.365	$0.39	$0.345	$0.35	398K	▼-1.41%
11 June 2026	$0.365	$0.37	$0.355	$0.355	104K	▼-2.74%
10 June 2026	$0.36	$0.37	$0.36	$0.365	159K	▲+4.29%
9 June 2026	$0.365	$0.37	$0.34	$0.35	546K	▼-5.41%
8 June 2026	$0.375	$0.38	$0.365	$0.37	68K	–+0.00%
5 June 2026	$0.375	$0.38	$0.365	$0.37	68K	▼-2.63%
4 June 2026	$0.37	$0.39	$0.37	$0.38	247K	▲+2.70%
3 June 2026	$0.372	$0.375	$0.365	$0.37	73K	▲+2.78%
2 June 2026	$0.39	$0.39	$0.36	$0.36	355K	▼-6.49%
1 June 2026	$0.387	$0.387	$0.38	$0.385	52K	▲+1.32%
29 May 2026	$0.382	$0.382	$0.37	$0.38	55K	▼-2.56%
28 May 2026	$0.405	$0.405	$0.38	$0.39	264K	▼-1.27%
27 May 2026	$0.385	$0.395	$0.365	$0.395	321K	▲+5.33%
26 May 2026	$0.40	$0.40	$0.362	$0.375	221K	▼-8.54%
25 May 2026	$0.44	$0.442	$0.405	$0.41	365K	▼-5.75%
22 May 2026	$0.455	$0.455	$0.435	$0.435	406K	▼-2.25%
21 May 2026	$0.41	$0.48	$0.41	$0.445	1.3M	▲+8.54%
20 May 2026	$0.38	$0.41	$0.38	$0.41	179K	▲+10.81%
19 May 2026	$0.455	$0.46	$0.37	$0.37	1.3M	▼-12.94%
18 May 2026	$0.355	$0.47	$0.355	$0.425	2.3M	▲+21.43%
15 May 2026	$0.33	$0.36	$0.33	$0.35	213K	▲+6.06%
14 May 2026	$0.315	$0.335	$0.31	$0.33	237K	▲+3.13%
13 May 2026	$0.335	$0.335	$0.32	$0.32	340K	▼-5.88%
12 May 2026	$0.345	$0.347	$0.34	$0.34	334K	▼-2.02%
11 May 2026	$0.35	$0.352	$0.345	$0.347	64K	▼-1.42%
8 May 2026	$0.35	$0.352	$0.35	$0.352	51K	▲+0.57%
7 May 2026	$0.36	$0.36	$0.35	$0.35	70K	▼-2.78%
6 May 2026	$0.36	$0.36	$0.35	$0.36	219K	–+0.00%
5 May 2026	$0.37	$0.37	$0.35	$0.36	331K	▼-2.70%
4 May 2026	$0.37	$0.37	$0.365	$0.37	28K	–+0.00%

About Island Pharmaceuticals Limited

IPO Date

13 Apr 2021

CEO

David Charles Foster

Website

islandpharmaceuticals.com

ILA Frequently Asked Questions

What is the Island Pharmaceuticals (ASX: ILA) share price?

The ILA share price is $0.38, up 7.04% for the day, based on the latest available ASX market data.

What is Island Pharmaceuticals's market capitalisation?

Island Pharmaceuticals has a market capitalisation of $95.0M, making it the 834th-largest security listed on the ASX.

Does Island Pharmaceuticals pay a dividend?

ILA does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Island Pharmaceuticals profitable?

In its most recent reported period (ending 31 Dec 2025), ILA reported revenue of $0 and a net loss of $4.8M.

How many ILA shares are on issue?

Island Pharmaceuticals has approximately 250,066,137 shares on issue, based on its market capitalisation of $95.0M and current share price.

What sector is Island Pharmaceuticals in?

Island Pharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Island Pharmaceuticals list on the ASX?

Island Pharmaceuticals listed on the Australian Securities Exchange on 13 Apr 2021.

Company

Market Cap

Price

P/E

Div Yield

1D Change

SPLStarpharma Holdings Limited

$286.2M

$0.68

27.58

0.00%

▲+1.49%

RCERecce Pharmaceuticals Ltd

$144.6M

$0.50

-2.84

0.00%

▲+2.04%

ACWActinogen Medical Limited

$122.0M

$0.034

-4.28

0.00%

–+0.00%

ATHAlterity Therapeutics Limited

$107.7M

$0.495

-2.12

0.00%

▲+11.24%

ALAArovella Therapeutics Limited

$81.0M

$0.067

-14.80

0.00%

▲+1.52%

BIOBiome Australia Limited

$62.7M

$0.275

19.71

0.00%

–+0.00%

ATXAmplia Therapeutics Limited

$56.5M

$0.11

-8.54

0.00%

–+0.00%

TRJTrajan Group Holdings Limited

$49.7M

$0.325

-59.43

0.00%

▲+10.17%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.365	$0.39	$0.345	$0.35	398K	▼-1.41%
11 June 2026	$0.365	$0.37	$0.355	$0.355	104K	▼-2.74%
10 June 2026	$0.36	$0.37	$0.36	$0.365	159K	▲+4.29%
9 June 2026	$0.365	$0.37	$0.34	$0.35	546K	▼-5.41%
8 June 2026	$0.375	$0.38	$0.365	$0.37	68K	–+0.00%
5 June 2026	$0.375	$0.38	$0.365	$0.37	68K	▼-2.63%
4 June 2026	$0.37	$0.39	$0.37	$0.38	247K	▲+2.70%
3 June 2026	$0.372	$0.375	$0.365	$0.37	73K	▲+2.78%
2 June 2026	$0.39	$0.39	$0.36	$0.36	355K	▼-6.49%
1 June 2026	$0.387	$0.387	$0.38	$0.385	52K	▲+1.32%
29 May 2026	$0.382	$0.382	$0.37	$0.38	55K	▼-2.56%
28 May 2026	$0.405	$0.405	$0.38	$0.39	264K	▼-1.27%
27 May 2026	$0.385	$0.395	$0.365	$0.395	321K	▲+5.33%
26 May 2026	$0.40	$0.40	$0.362	$0.375	221K	▼-8.54%
25 May 2026	$0.44	$0.442	$0.405	$0.41	365K	▼-5.75%
22 May 2026	$0.455	$0.455	$0.435	$0.435	406K	▼-2.25%
21 May 2026	$0.41	$0.48	$0.41	$0.445	1.3M	▲+8.54%
20 May 2026	$0.38	$0.41	$0.38	$0.41	179K	▲+10.81%
19 May 2026	$0.455	$0.46	$0.37	$0.37	1.3M	▼-12.94%
18 May 2026	$0.355	$0.47	$0.355	$0.425	2.3M	▲+21.43%
15 May 2026	$0.33	$0.36	$0.33	$0.35	213K	▲+6.06%
14 May 2026	$0.315	$0.335	$0.31	$0.33	237K	▲+3.13%
13 May 2026	$0.335	$0.335	$0.32	$0.32	340K	▼-5.88%
12 May 2026	$0.345	$0.347	$0.34	$0.34	334K	▼-2.02%
11 May 2026	$0.35	$0.352	$0.345	$0.347	64K	▼-1.42%
8 May 2026	$0.35	$0.352	$0.35	$0.352	51K	▲+0.57%
7 May 2026	$0.36	$0.36	$0.35	$0.35	70K	▼-2.78%
6 May 2026	$0.36	$0.36	$0.35	$0.36	219K	–+0.00%
5 May 2026	$0.37	$0.37	$0.35	$0.36	331K	▼-2.70%
4 May 2026	$0.37	$0.37	$0.365	$0.37	28K	–+0.00%